Citations

Clear

367 citation(s) found for "Benson, Al".

Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosis
O’Donnell, Ellen , Schuette, Allison , Waltz, Michael , Aaen, Gregory , Gorman, Mark , Lotze, Timothy , Mar, Soe , Ness, Jayne , Tillema, Jan‐Mendelt , Schreiner, Teri , Wheeler, Yolanda , Casper, T. Charles , Benson, Leslie, Rodriguez, Moses , Schreiner, Teri , Chitnis, Tanuja

Mayo Clinic

Multiple Sclerosis Journal | September 17, 2024 | Volume: 30 | Issue: 11-12 | Pages: 1525-1543

10.1177/13524585241274580 | PMID 39286941 Get It

Background and Objectives: This survey study aimed to (1) identify patient/family research priorities in pediatric-onset multiple sclerosis (POMS), and (2) delineate optimized methods for research study/clinical trials design, engagement, and implementation. Methods: Participants were as follows: (1) parents of a child (<18 years) with POMS enrolled in a national registry, (2) adolescents (13–17 years) with POMS in the registry, and (3) adults (18–40 years) with POMS receiving care at a registry affiliated clinic. Of 293 eligible participants, 192 completed surveys. Results: Experiences with health care and medications were generally positive but there remain areas of priority improvement. Incentives to participate in clinical trials included medications previously tested and in pill form, bloodwork/study visits required ⩾ every 3 months, cognitive testing ⩽1 hour, compensation for travel and time, ability to continue current multiple sclerosis (MS) medication, option to take study medication if on placebo, and individualized study feedback. Priorities for clinical research were (1) psychosocial impact, (2) cognitive/academic impact, (3) environmental risk, and (4) nutrition. Conclusions: Results highlighted the importance of a holistic approach to study design and a focus on the impact of disease on daily life to best engage patients and families in POMS clinical trials and research.
Iltamiocel Autologous Cell Therapy for the Treatment of Female Stress Urinary Incontinence: A Double‐Blind, Randomized, Stratified, Placebo‐Controlled Trial
Kaufman, Melissa R. , Goldman, Howard B. , Chermansky, Christopher , Dmochowski, Roger R. , Peters, Kenneth M. , Quiroz, Lieschen H. , Bennett, Jason , Thomas, Sherry , Marguet, Charles G., Benson, Kevin , Wolter, Christopher , Katz, Daniel , Tarnay, Christopher M. , Antosh, Danielle D. , Heit, Michael , Rehme, Christian, Karram, Mickey M., Canestrari, Emanuele , Jankowski, Ron J. , Chermansky, Christopher J , Dmochowski, Roger , Lee, Una J , Wolter, Christopher E, Canestrari, Emanuele , Jankowski, Ron J , Chancellor, Michael B , KENNELLY, MICHAEL J. , Sokol, Eric R. , Katz, Daniel M., Snyder, Scott

Mayo Clinic

Neurourology and Urodynamics | September 16, 2024 | Volume: 43 | Issue: 8 | Pages: 2290-2299

10.1002/nau.25588 | PMID 39282854 Get It

ABSTRACTAimsThis study aimed to determine the efficacy and safety of iltamiocel investigational autologous muscle cell therapy in females with stress urinary incontinence (SUI).MethodsAdult females were randomized 2:1 to iltamiocel (150 × 106 cells) or placebo and stratified by severity and prior SUI surgery. The primary objective was efficacy based on the frequency of stress incontinence episodes (SIE) recorded in a 3‐day diary at 12 months posttreatment. After 12 months, placebo participants could elect to receive open‐label iltamiocel. Efficacy and safety analyses were performed using all patients as treated populations.ResultsThe study enrolled 311 patients, 297 were randomized to either iltamiocel (n = 199) or placebo (n = 98). Of the 295 participants that completed 12 months blinded follow‐up, the proportion achieving the primary endpoint of ≥ 50% SIE reduction was not statistically different between treatment groups (52% vs. 53.6%; p = 0.798). A significantly greater proportion of iltamiocel participants in the prior SUI surgery stratum group achieved ≥ 75% SIE reduction compared with placebo, (40% vs. 16%; p = 0.037). Treatment response was maintained at 24 months in 78.4% and 64.9% of iltamiocel participants who achieved ≥ 50% and ≥ 75% SIE reduction, respectively, at Month 12. Adverse events related to the treatment were reported in 19 (9.5%) iltamiocel participants and 6 (6.1%) placebo participants.ConclusionThe study did not meet its primary endpoint however, iltamiocel cell therapy is safe and may be ideally suited to female patients who have undergone prior surgery for SUI. Additional study in this group of patients with high unmet medical needs is warranted.Trial RegistrationClinicalTrials.gov identifier: NCT01893138; EudraCT number: 2014‐002919‐41.
Improved visualization of the chorda tympani with photon counting detector CT
Joseph, Annie K. , Farnsworth, Paul J. , Carlson, Matthew L. , Benson, John C. , Madhavan, Ajay A. , Lane, John I. , Benson, John , Madhavan, Ajay A , Farnsworth, Paul , Campeau, Norbert G. , Leng, Shuai

Mayo Clinic

Clinical Neuroimaging | August 17, 2024 | Volume: 1 | Issue: 1-2 | Pages: No page available

10.1002/neo2.18 Get It

AbstractBackground and PurposeTo compare the performance of the photon‐counting detector (PCD)‐CT against a cutting‐edge energy‐integrated detector (EID)‐CT to visualize different segments of the chorda tympani nerve.Materials and MethodsAn IRB‐approved protocol prospectively enrolled patients for temporal bone CT on both EID‐CT and PCD‐CT scanners. Fellowship‐trained neuroradiologists compared visualization of chorda tympani segments on each scanner using a 5‐point Likert scale (1 indicating EID is far superior to PCD, 3 indicating they are equivalent, and 5 indicating PCD is far superior to EID). Scores were averaged across segments and tested using a one‐sample Wilcoxon signed‐rank test with a one‐sided alternative hypothesis.ResultsForty temporal bones were evaluated. Average Likert scores for visualization of chorda tympani segments‐chorda tympani canal/proximal segment, middle ear/posterior tympanic segment, and petrotympanic fissure/distal segment‐ on the PCD compared to EID scanner were 4.2 (SD = 0.4), 4.4 (0.5), and 4 (0.0), respectively. The anterior tympanic segment of the chorda tympani was not well visualized on either platform or therefore not scored. PCD compared to the EID scanner had better overall performance (Median = 4.2, 95% CI: [4.1, 5.0], p‐value < .001).ConclusionPCD‐CT improves visualization of the petrous and intratympanic chorda tympani nerve segments, chorda tympani canaliculus, and petrotympanic fissure compared to comparable EID‐CT examinations. The improved visualization of the chorda tympani is important for the characterization of middle ear pathology involving this structure and presurgical planning to determine the size of the facial recess for cochlear implantation and to estimate the risk of nerve injury.
NCCN Guidelines® Insights: Rectal Cancer, Version 3.2024
Benson, Al B. , Adam, Mohamed A. , Chang, George J. , Chen, Yi-Jen, Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Haste, Paul, Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Joseph, Nora, Kirilcuk, Natalie, Krishnamurthi, Smitha , Malla, Midhun , Maratt, Jennifer K. , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Parikh, Aparna, Patel, Hitendra , Shibata, David , Shogan, Benjamin D. , Skibber, John M., Sofocleous, Constantinos T. , Tavakkoli, Anna , Willett, Christopher G. , Wu, Christina, Jones, Frankie, Gurski, Lisa A., Meyerhardt, Jeffrey A , Venook, Alan P. , Chen, Yi‐Jen , Ciombor, Kristen K. , Cohen, Stacey A. , Hussan, Hisham , Miller, Eric D. , Patel, Hitendra, Pedersen, Katrina S. , Saltz, Leonard B. , Schneider, Charles John

Mayo Clinic

Journal of the National Comprehensive Cancer Network | August 16, 2024 | Volume: 22 | Issue: 6 | Pages: 366-375

10.6004/jnccn.2024.0041 | PMID 39151454 Get It

The determination of an optimal treatment plan for an individual patient with rectal cancer is a complex process. In addition to decisions relating to the intent of rectal cancer surgery (ie, curative or palliative), consideration must also be given to the likely functional results of treatment, including the probability of maintaining or restoring normal bowel function/anal continence and preserving genitourinary functions. Particularly for patients with distal rectal cancer, finding a balance between curative-intent therapy while having minimal impact on quality of life can be challenging. Furthermore, the risk of pelvic recurrence is higher in patients with rectal cancer compared with those with colon cancer, and locally recurrent rectal cancer is associated with a poor prognosis. Careful patient selection and the use of sequenced multimodality therapy following a multidisciplinary approach is recommended. These NCCN Guidelines Insights detail recent updates to the NCCN Guidelines for Rectal Cancer, including the addition of endoscopic submucosal dissection as an option for early-stage rectal cancer, updates to the total neoadjuvant therapy approach based on the results of recent clinical trials, and the addition of a “watch-and-wait” nonoperative management approach for clinical complete responders to neoadjuvant therapy.
Soft tissue aneurysmal bone cyst presenting as an enlarging neck mass: Case report and review of the head and neck literature
Chan, Stephen A. , Benson, John C. , Wittich, Michelle A. Neben, Chatzopoulos, Kyriakos , García, Joaquín J. , Geiersbach, Katherine B. , Gruber, Lucinda , Wermers, Robert A. , Pignolo, Robert J. , Rose, Peter S. , Abel, Kathryn M. Van , Neben Wittich, Michelle A, Van Abel, Kathryn M , Benson, John , Geiersbach, Katherine

Mayo Clinic

The Neuroradiology Journal | August 6, 2024 | Volume: 38 | Issue: 3 | Pages: 377-381

10.1177/19714009241269441 | PMID 39106298 Get It

Soft tissue aneurysmal bone cysts (STABCs) are rare neoplasms histopathologically identical to aneurysmal bone cysts. These benign lesions are characterized by thin, peripheral ossification and no skeletal continuity. STABC may be difficult to distinguish from myositis ossificans (MO) and malignant entities from imaging and fine needle aspiration, due to rarity and overlapping features. We present a case of a STABC occurring in the paraspinal cervical muscles. The imaging, histopathology, molecular analysis, and treatment are discussed. Four other published cases of STABC of the head and neck are reviewed.
Association of nutritional intake with clinical and imaging activity in pediatric multiple sclerosis
Mohan, Sonam D, Peterson, Skyler, Brenton, J. Nicholas , Carmichael, Suzan L. , Virupakshaiah, Akash , Tillema, Jan‐Mendelt , Mar, Soe , Rensel, Mary , Abrams, Aaron , Gorman, Mark , Lotze, Tim, Shukla, Nikita, Graves, Jennifer, Aaen, Gregory , Casper, T. Charles , Rensel, Mary R. , Abrams, Aaron , Chitnis, Tanuja , Brenton, J Nicholas , Virupakshaiah, Akash , Rodriguez, Moses , Benson, Leslie, Waubant, Emmanuelle L.

Mayo Clinic

Multiple Sclerosis Journal | July 30, 2024 | Volume: 30 | Issue: 8 | Pages: 1056-1065

10.1177/13524585241261556 | PMID 39078111 Get It

Background: Understanding nutrition’s role in multiple sclerosis (MS) can guide recommendations and intervention-based studies. Objective: Evaluate the association between nutrition and pediatric-onset MS outcomes. Methods: Prospective longitudinal multicenter study conducted as part of the US Network of Pediatric MS centers. Predictors were collected using a food screener estimating intake of various dietary food groups (e.g. dairy and fruits) and additional calculated indices (e.g. Healthy Eating Index (HEI)). Outcomes included time-from-enrollment to clinical relapse, new magnetic resonance imaging (MRI) T2 lesions, and Expanded Disability Status Scale (EDSS) increase. Results: 353 children with MS were enrolled (mean ± SD age 15.4 ± 2.9, follow-up 3.9 ± 2.6 years). Multivariable analysis demonstrated that increased dairy by 50% of recommended intake was associated with increased relapse risk by 41% (adjusted hazard ratio (HR) 1.41, 95% CI 1.07–1.86), and risk of T2 progression by 40% (1.40, 1.12–1.74). Increased intake of fruit or vegetable above recommended, and every five-point HEI increase decreased relapse risk by 25% (0.75, 0.60–0.95), 45% (0.55, 0.32–0.96), and 15% (0.84, 0.74–0.96), respectively. No associations were found with EDSS. Conclusion: This work supports the influence of dietary intake on MS course, particularly with dairy intake. Future prospective study is required to establish causation.
O-069 CSF-venous fistula transvenous embolization: incidence of onyx migration and suggestion of one-way fistula physiology
Michaelcheck, Charlotte E., Brinjikji, Waleed , Verdoorn, Jared T. , Cutsforth‐Gregory, Jeremy K. , Cogswell, Petrice M. , Benson, John C. , Madhavan, Ajay A. , Mark, Ian T.

Mayo Clinic

SNIS 21st annual meeting oral abstracts | July 22, 2024 | Volume: No volume available | Issue: No issue available | Pages: A52.1-A52

10.1136/jnis-2024-snis.69 Get It

Machine Learning Detects Symptomatic Plaques in Patients With Carotid Atherosclerosis on CT Angiography
Pisu, Francesco , Williamson, Brady J. , Nardi, Valentina , Paraskevas, Kosmas I. , Vagal, Achala , Rubeis, Gianluca De , Porcu, Michele , Cau, Riccardo , Benson, John C. , Balestrieri, Antonella , Suri, Jasjit S. , Saba, Luca , Vagal, Achala , De Rubeis, Gianluca , Porcu, Michele , Cau, Riccardo , Benson, John , Balestrieri, Antonella , Lanzino, Giuseppe , Saba, Luca , Paraskevas, Kosmas I , Nardi, Valentina , Puig, Josep , Lanzino, Giuseppe , Suri, Jasjit S. , Mahammedi, Abdelkader

Mayo Clinic

Circulation: Cardiovascular Imaging | June 18, 2024 | Volume: 17 | Issue: 6 | Pages: No page available

10.1161/circimaging.123.016274 | PMID 38889214 Get It

BACKGROUND: This study aimed to develop and validate a computed tomography angiography based machine learning model that uses plaque composition data and degree of carotid stenosis to detect symptomatic carotid plaques in patients with carotid atherosclerosis. METHODS: The machine learning based model was trained using degree of stenosis and the volumes of 13 computed tomography angiography derived intracarotid plaque subcomponents (eg, lipid, intraplaque hemorrhage, calcium) to identify plaques associated with cerebrovascular events. The model was internally validated through repeated 10-fold cross-validation and tested on a dedicated testing cohort according to discrimination and calibration. RESULTS: This retrospective, single-center study evaluated computed tomography angiography scans of 268 patients with both symptomatic and asymptomatic carotid atherosclerosis (163 for the derivation set and 106 for the testing set) performed between March 2013 and October 2019. The area-under-receiver-operating characteristics curve by machine learning on the testing cohort (0.89) was significantly higher than the areas under the curve of traditional logit analysis based on the degree of stenosis (0.51, P <0.001), presence of intraplaque hemorrhage (0.69, P <0.001), and plaque composition (0.78, P <0.001), respectively. Comparable performance was obtained on internal validation. The identified plaque components and associated cutoff values that were significantly associated with a higher likelihood of symptomatic status after adjustment were the ratio of intraplaque hemorrhage to lipid volume (≥50%, 38.5 [10.1–205.1]; odds ratio, 95% CI) and percentage of intraplaque hemorrhage volume (≥10%, 18.5 [5.7–69.4]; odds ratio, 95% CI). CONCLUSIONS: This study presented an interpretable machine learning model that accurately identifies symptomatic carotid plaques using computed tomography angiography derived plaque composition features, aiding clinical decision-making.
Colon Cancer, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Adam, Mohamed A. , Chang, George J. , Chen, Yi-Jen, Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Haste, Paul, Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Joseph, Nora, Kirilcuk, Natalie, Krishnamurthi, Smitha , Malla, Midhun , Maratt, Jennifer K. , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Parikh, Aparna, Patel, Hitendra , Shibata, David , Shogan, Benjamin D. , Skibber, John M., Sofocleous, Constantinos T. , Tavakkoli, Anna , Willett, Christopher G. , Wu, Christina, Gurski, Lisa A., Snedeker, Jenna, Jones, Frankie, Meyerhardt, Jeffrey A , Venook, Alan P. , Chen, Yi‐Jen , Ciombor, Kristen K. , Cohen, Stacey A. , Hussan, Hisham , Miller, Eric D. , Patel, Hitendra, Pedersen, Katrina S. , Saltz, Leonard B. , Schneider, Charles John

Mayo Clinic

Journal of the National Comprehensive Cancer Network | June 11, 2024 | Volume: 22 | Issue: 2D | Pages: No page available

10.6004/jnccn.2024.0029 | PMID 38862008 Get It

Colorectal cancer (CRC) is the fourth most frequently diagnosed cancer and the second leading cause of cancer death in the United States. Management of disseminated metastatic CRC involves various active drugs, either in combination or as single agents. The choice of therapy is based on consideration of the goals of therapy, the type and timing of prior therapy, the mutational profile of the tumor, and the differing toxicity profiles of the constituent drugs. This manuscript summarizes the data supporting the systemic therapy options recommended for metastatic CRC in the NCCN Guidelines for Colon Cancer.
Carotid artery calcium score: Definition, classification, application, and limits
Saba, Luca , Benson, John C. , Scicolone, Roberta , Paraskevas, Kosmas I. , Gupta, Ajay , Cau, Riccardo , Suri, Jasjit S. , Schindler, Andreas , Balestrieri, Antonella , Nardi, Valentina , Song, Jae W , Wintermark, Max , Benson, John , Paraskevas, Kosmas I , Cau, Riccardo , Nardi, Valentina , Saba, Luca , Suri, Jasjit S. , Song, Jae W. , Wintermark, Max , Lanzino, Giuseppe

Mayo Clinic

The Neuroradiology Journal | May 8, 2024 | Volume: 37 | Issue: 5 | Pages: 611-619

10.1177/19714009241252623 | PMID 38718167 Get It

Introduction In the current paper, the “carotid artery calcium score” method is presented with the target to offer a metric method to quantify the amount of calcification in the carotid artery. Model and Definition The Volume of Interest (VOI) should be extracted and those voxels, with a Hounsfield Unit (HU) value ≥130, should be considered. The total weight value is determined by calculating the sum of the HU attenuation values of all voxels with values ≥130 HU. This value should be multiplied by the conversion factor (“or voxel size”) and divided by a weighting factor, the attenuation threshold to consider a voxel as calcified (and therefore 130 HU): this equation determines the Carotid Artery Calcium Score (CACS). Results In order to provide the demonstration of the potential feasibility of the model, the CACS was calculated in 131 subjects (94 males; mean age 72.7 years) for 235 carotid arteries (in 27 subjects, unilateral plaque was present) considered. The CACS value ranged from 0.67 to 11716. A statistically significant correlation was found (rho value = 0.663, p value = .0001) between the CACS in the right and left carotid plaques. Moreover, a statistically significant correlation between the age and the total CACS was present (rho value = 0.244, p value = .005), whereas no statistically significant difference was found in the distribution of CACS by gender ( p = .148). The CACS was also tested at baseline and after contrast and no statistically significant difference was found. Conclusion In conclusion, this method is of easy application, and it weights at the same time the volume and the degree of calcification in a unique parameter. This method needs to be tested to verify its potential utility, similar to the coronary artery calcium score, for the risk stratification of the occurrence of cerebrovascular events of the anterior circulation. Further studies using this new diagnostic tool to determine the prognostic value of carotid calcium quantification are needed.